Focused on the treatment of orphan diseases of the liver relating to the urea cycle.
Industry: Health Care
First Day Return: +1.1%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 04/13/2012 |
Offer Price | $10.00 |
Price Range $11.00 - $13.00 | |
Offer Shares (mm) | 5.0 |
Deal Size ($mm) | $50 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/25/2012 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $50 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | South San Francisco, CA, United States |
Founded | 2006 |
Employees at IPO | 14 |
Website www.hyperiontx.com |